Skip to main content
Journal cover image

Imaging of Clinically Unrecognized Myocardial Fibrosis in Patients With Suspected Coronary Artery Disease.

Publication ,  Journal Article
Antiochos, P; Ge, Y; Steel, K; Bingham, S; Abdullah, S; Mikolich, JR; Arai, AE; Bandettini, WP; Patel, AR; Farzaneh-Far, A; Heitner, JF ...
Published in: J Am Coll Cardiol
August 25, 2020

BACKGROUND: Stress cardiac magnetic resonance (CMR) provides accurate assessment of both myocardial infarction (MI) and ischemia. OBJECTIVES: This study aimed to evaluate the incremental prognostic value of unrecognized myocardial infarction (UMI), detected during assessment of coronary artery disease (CAD) by stress CMR, beyond cardiac function and ischemia. METHODS: In the multicenter SPINS (Stress CMR Perfusion Imaging in the United States) study, 2,349 consecutive patients (63 ± 11 years of age, 53% were male) with suspected CAD were assessed by stress CMR and followed over a median of 5.4 years. UMI was defined as the presence of late gadolinium enhancement consistent with MI in the absence of medical history of MI. This study investigated the association of UMI with all-cause mortality and nonfatal MI (death and/or MI), and major adverse cardiac events (MACE). RESULTS: UMI was detected in 347 patients (14.8%) and clinically recognized myocardial infarction (RMI) in 358 patients (15.2%). Compared with patients with RMI, patients with UMI had a similar burden of cardiovascular risk factors, but significantly lower left ventricular ejection fraction (p < 0.001) and lower rates of guideline-directed medical therapies, including aspirin (p < 0.001), statin (p < 0.001), and beta-blockers (p = 0.002). During follow-up, 328 deaths and/or MIs and 528 MACE occurred. In univariate analysis, UMI and RMI were strongly associated with death and/or MI (UMI: hazard ratio [HR]: 2.15; 95% confidence interval [CI]: 1.63 to 2.83; p < 0.001; RMI: HR: 2.45; 95% CI: 1.89 to 3.18) and MACE. Compared with patients with RMI, patients with UMI presented an increased risk for heart failure hospitalization (UMI vs. RMI: HR: 2.60; 95% CI: 1.48 to 4.58; p < 0.001). In a multivariate model including ischemia and left ventricular ejection fraction, UMI and RMI maintained robust prognostic association with death and/or MI (UMI: HR: 1.82; 95% CI: 1.37 to 2.42; p < 0.001; RMI: HR: 1.54; 95% CI: 1.14 to 2.09) and MACE. CONCLUSIONS: In a multicenter cohort of patients with suspected CAD, presence of UMI or RMI portended an equally significant risk for death and/or MI, independently of the presence of ischemia. Compared with RMI patients, those with UMI were less likely to receive guideline-directed medical therapies and presented an increased risk for heart failure hospitalization that warrants further study. (Stress CMR Perfusion Imaging in the United States [SPINS]; NCT03192891).

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

August 25, 2020

Volume

76

Issue

8

Start / End Page

945 / 957

Location

United States

Related Subject Headings

  • Risk Assessment
  • Prognosis
  • Outcome and Process Assessment, Health Care
  • Myocardial Perfusion Imaging
  • Myocardial Ischemia
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Magnetic Resonance Angiography
  • Image Enhancement
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Antiochos, P., Ge, Y., Steel, K., Bingham, S., Abdullah, S., Mikolich, J. R., … SPINS Study Investigators, . (2020). Imaging of Clinically Unrecognized Myocardial Fibrosis in Patients With Suspected Coronary Artery Disease. J Am Coll Cardiol, 76(8), 945–957. https://doi.org/10.1016/j.jacc.2020.06.063
Antiochos, Panagiotis, Yin Ge, Kevin Steel, Scott Bingham, Shuaib Abdullah, J Ronald Mikolich, Andrew E. Arai, et al. “Imaging of Clinically Unrecognized Myocardial Fibrosis in Patients With Suspected Coronary Artery Disease.J Am Coll Cardiol 76, no. 8 (August 25, 2020): 945–57. https://doi.org/10.1016/j.jacc.2020.06.063.
Antiochos P, Ge Y, Steel K, Bingham S, Abdullah S, Mikolich JR, et al. Imaging of Clinically Unrecognized Myocardial Fibrosis in Patients With Suspected Coronary Artery Disease. J Am Coll Cardiol. 2020 Aug 25;76(8):945–57.
Antiochos, Panagiotis, et al. “Imaging of Clinically Unrecognized Myocardial Fibrosis in Patients With Suspected Coronary Artery Disease.J Am Coll Cardiol, vol. 76, no. 8, Aug. 2020, pp. 945–57. Pubmed, doi:10.1016/j.jacc.2020.06.063.
Antiochos P, Ge Y, Steel K, Bingham S, Abdullah S, Mikolich JR, Arai AE, Bandettini WP, Patel AR, Farzaneh-Far A, Heitner JF, Shenoy C, Leung SW, Gonzalez JA, Shah DJ, Raman SV, Ferrari VA, Schulz-Menger J, Stuber M, Simonetti OP, Kwong RY, SPINS Study Investigators. Imaging of Clinically Unrecognized Myocardial Fibrosis in Patients With Suspected Coronary Artery Disease. J Am Coll Cardiol. 2020 Aug 25;76(8):945–957.
Journal cover image

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

August 25, 2020

Volume

76

Issue

8

Start / End Page

945 / 957

Location

United States

Related Subject Headings

  • Risk Assessment
  • Prognosis
  • Outcome and Process Assessment, Health Care
  • Myocardial Perfusion Imaging
  • Myocardial Ischemia
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Magnetic Resonance Angiography
  • Image Enhancement